Edward Carr is Chief Financial Officer of ABEONA THERAPEUTICS INC.. Currently has a direct ownership of 400,169 shares of ABEO, which is worth approximately $2.28 Million. The most recent transaction as insider was on Oct 08, 2021, when has been sold 29,122 shares (Common Stock) at a price of $1.05 per share, resulting in proceeds of $30,578. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 400K
0% 3M change
0% 12M change
Total Value Held $2.28 Million

EDWARD CARR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 08 2021
SELL
Open market or private sale
$30,578 $1.05 p/Share
29,122 Reduced 6.78%
400,169 Common Stock
Aug 10 2021
BUY
Grant, award, or other acquisition
-
238,000 Added 35.67%
429,291 Common Stock
Apr 05 2021
SELL
Open market or private sale
$63,000 $1.8 p/Share
35,000 Reduced 15.47%
191,291 Common Stock
Apr 01 2021
SELL
Open market or private sale
$37,823 $1.85 p/Share
20,445 Reduced 8.29%
226,291 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
50,000 Added 16.85%
246,736 Common Stock
Oct 09 2020
BUY
Grant, award, or other acquisition
-
143,182 Added 42.12%
196,736 Common Stock

Also insider at

MGTA
Magenta Therapeutics, Inc. Healthcare
EC

Edward Carr

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on ABEO

Follow ABEONA THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABEO shares.

Notify only if

Insider Trading

Get notified when an Abeona Therapeutics Inc. insider buys or sells ABEO shares.

Notify only if

News

Receive news related to ABEONA THERAPEUTICS INC.

Track Activities on ABEO